The market for home infusion services is approaching $10 billion annually. The amount is split almost evenly between reimbursement for drug product and for the services pharmacists provide in preparing, delivering, and supporting home IV therapy.
How Mark Cuban Cost Plus Drug Company Is Approaching Drug Pricing Transparency
October 14th 2024Erin Albert, vice president of pharmacy relations and chief privacy officer at Mark Cuban Cost Plus Drug Company, PBC, discussed drug pricing and what her company is doing to revolutionize transparency.